$TGTX CEO Joaquin Duato has repeatedly emphasized that J&J’s capital allocation strategy prioritizes high-growth, high-margin therapeutic areas, specifically oncology, immunology, and neuroscience -the exact three categories targeted by Briumvi (oncology roots, autoimmune MS/

stocktwits · 2026-08-25 · Bullish AI sentiment

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。